NEA Management Company, LLC Long-Term Concentrated

CIK: 0001512848 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Oct 24, 2014

Total Value ($000): $1,967,502 (100.0% shares, 0.0% debt)

Holdings (35)

GROUPON INC 18.5%
Value ($000) $363,069 Shares 54,351,573 Est. Cost $8.55 Unrealized
TESARO INC 13.5%
Value ($000) $265,277 Shares 9,854,255 Est. Cost $32.74 Unrealized
OPOWER INC 8.6%
Value ($000) $169,689 Shares 8,997,290 Est. Cost $18.85 Unrealized
EPIZYME INC 7.1%
Value ($000) $139,609 Shares 5,149,740 Est. Cost $27.67 Unrealized
CVENT INC 6.4%
Value ($000) $126,700 Shares 4,994,106 Est. Cost $35.17 Unrealized
CLOVIS ONCOLOGY INC 5.3%
Value ($000) $103,411 Shares 2,279,781 Est. Cost $66.98 Unrealized
ARDX ARDELYX INC 4.8%
Value ($000) $94,087 Shares 6,621,199 Est. Cost $14.46 Unrealized 0.0%
SUPN SUPERNUS PHARMACEUTICALS INC 4.7%
Value ($000) $92,549 Shares 10,650,000 Est. Cost $5.89 Unrealized +53.4%
HYPERION THERAPEUTICS INC 3.1%
Value ($000) $60,130 Shares 2,384,221 Est. Cost $22.00 Unrealized
GLYCOMIMETICS INC 3.0%
Value ($000) $59,511 Shares 8,575,135 Est. Cost $16.33 Unrealized
TRIVASCULAR TECHNOLOGIES INC 2.9%
Value ($000) $57,126 Shares 3,945,191 Est. Cost $15.57 Unrealized
PROSENSA HLDG NV 2.8%
Value ($000) $54,628 Shares 6,480,171 Est. Cost $5.63 Unrealized
AEROHIVE NETWORKS INC 2.0%
Value ($000) $38,989 Shares 4,861,455 Est. Cost $8.02 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.7%
Value ($000) $33,636 Shares 5,653,029 Est. Cost $3.07 Unrealized +70.5%
SUNESIS PHARMACEUTICALS INC 1.7%
Value ($000) $33,268 Shares 4,659,333 Est. Cost $5.19 Unrealized
ROKA BIOSCIENCE INC 1.6%
Value ($000) $32,365 Shares 3,220,433 Est. Cost $10.05 Unrealized
BOINGO WIRELESS INC 1.6%
Value ($000) $31,857 Shares 4,467,960 Est. Cost $6.21 Unrealized
CARE COM INC 1.4%
Value ($000) $26,577 Shares 3,260,989 Est. Cost $8.15 Unrealized
TREVENA INC 1.2%
Value ($000) $24,471 Shares 3,811,691 Est. Cost $7.86 Unrealized
NEKTAR THERAPEUTICS 1.1%
Value ($000) $22,035 Shares 1,825,600 Est. Cost $11.55 Unrealized
VITAE PHARMACEUTICALS INC 1.0%
Value ($000) $19,939 Shares 2,613,199 Est. Cost $7.63 Unrealized
LEXICON PHARMACEUTICALS INC 0.8%
Value ($000) $16,463 Shares 11,676,000 Est. Cost $2.17 Unrealized
OREXIGEN THERAPEUTICS INC 0.8%
Value ($000) $15,800 Shares 3,709,000 Est. Cost $5.13 Unrealized
MILLENNIAL MEDIA INC 0.8%
Value ($000) $15,298 Shares 8,224,752 Est. Cost $8.71 Unrealized
ZHONE TECHNOLOGIES INC 0.7%
Value ($000) $12,909 Shares 4,781,290 Est. Cost $0.80 Unrealized
ALIMERA SCIENCES INC 0.6%
Value ($000) $12,226 Shares 2,255,639 Est. Cost $4.70 Unrealized
TARGACEPT INC 0.6%
Value ($000) $11,554 Shares 4,566,666 Est. Cost $4.27 Unrealized
CHANNELADVISOR CORP 0.5%
Value ($000) $9,130 Shares 556,692 Est. Cost $15.73 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 0.4%
Value ($000) $8,150 Shares 2,546,843 Est. Cost $3.55 Unrealized 0.0%
RIGEL PHARMACEUTICALS INC 0.3%
Value ($000) $6,292 Shares 3,243,150 Est. Cost $3.34 Unrealized
TRANSCEPT PHARMACEUTICALS INC 0.2%
Value ($000) $4,236 Shares 2,086,755 Est. Cost $3.02 Unrealized
EXEL EXELIXIS INC 0.2%
Value ($000) $3,377 Shares 2,207,000 Est. Cost $4.74 Unrealized -32.3%
ARQULE INC 0.1%
Value ($000) $2,823 Shares 2,520,316 Est. Cost $2.32 Unrealized
AGILE THERAPEUTICS INC 0.0%
Value ($000) $218 Shares 29,850 Est. Cost $8.33 Unrealized
NEUROMETRIX INC 0.0%
Value ($000) $103 Shares 57,273 Est. Cost $2.01 Unrealized